Cardiovascular Systems, Inc. Receives Approval for the Diamondback 360® Coronary Orbital Atherectomy System (OAS) Micro Crown in the United States OAS Micro Crown Approved to Treat Severely Calcified Coronary Lesions Only Atherectomy Device Designed to Both Pilot Tight Lesions and […]
Author: Ken Dropiewski
Utah’s Merit Medical (MMSI) Prices $136.5 Million Offering
Merit Medical Announces Closing of Public Offering of Common Stock SOUTH JORDAN, Utah, March 29, 2017 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI) (“Merit”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic […]
Boston Scientific agrees to acquire Symetis
MARLBOROUGH, Mass., March 30, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices, for $435 million in up-front cash. The […]
Study Suggests Marijuana Use Can Bring a Greater Risk of Cardiovascular Disease
By Ken Dropiewski, Ken@Prime-Core.com According to LiveScience, a study conducted by the Einstein Medical Center in Philadelphia suggests that marijuana users have an increased risk of a number of cardiovascular diseases, including strokes and heart failure. The study did have some […]
New Guidelines Support Use of Cardiac Monitoring for Patients with Unexplained Fainting
Press Release American College of Cardiology, American Heart Association and Heart Rhythm Society Jointly Issue First-Ever Syncope Guidelines that Reinforce Benefits of Continuous Cardiac Monitoring DUBLIN – March 24, 2017 – Newly published guidelines from the American College of Cardiology […]
Surgery Without the Knife: Mirabilis Medical Announces European Approval for Non-Invasive Uterine Fibroid Treatment
BOTHELL, Wash., March 23, 2017 /PRNewswire/ — Mirabilis Medical, a Seattle-area developer of advanced medical technology for non-invasive surgery, announced today CE Mark authorization for marketing of the Mirabilis System for treatment of uterine fibroids throughout the European Union. The company […]
AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System
ALBANY, N.Y., March 14, 2017 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology/surgery, today announced it has received CE Mark certification for the Solero Microwave Tissue […]
NEWS RELEASE Biosensors Announces Enrollment of the First American Patient in the new US Pivotal BioFreedom Trial – “LEADERS FREE II”
Press Release Singapore, 22 March 2017 – Biosensors International Group, Ltd. (“Biosensors” or the “Company”), a developer, manufacturer and marketer of innovative medical devices, announced today the enrollment of the first American patient in LEADERS FREE II, its new BioFreedom […]
Metactive Medical Announces Issuance of Patents on Blockstent and Ballstent Embolization Devices
OLATHE, Kan.–(BUSINESS WIRE)–Metactive Medical Inc. (Metactive), an early-stage company focused on developing embolization devices for the treatment of peripheral vascular and neurovascular diseases, today announced the issuance of US Patents 9,572,697 and 9,572,698 covering its Ballstent Microcatheter™ for embolization of […]
Humacyte Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Expedited Review Designation for HUMACYL® in Vascular Access for Hemodialysis
Press Release RESEARCH TRIANGLE PARK, N.C. — Humacyte, an innovator in biotechnology and regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted HUMACYL®, its investigational human acellular vessel (HAV), the Regenerative Medicine Advanced Therapy (RMAT) […]